Labour MP: our candidate was a ‘drug pusher’
Dec 7 2006
Martin Shipton, Western Mail
A WELSH Labour MP has gone off message [really?] by describing his party’s unsuccessful Blaenau Gwent by-election candidate [Blairite] Owen Smith as a “drug pusher”.
In an interview with the cultural magazine Planet, Newport West MP Paul Flynn also took issue with those in the party who had described the [Left anti Blair] Independent candidate who beat Mr Smith as lacking “validity”.
Mr Flynn said, “The lobbyists are a curse, a cancer in the system. It’s insidious.
One of my main interests in politics is areas in which lobbyists used their wicked wiles to get access to government.
One example is the pharmaceutical industry, who are the most greedy and deceitful organisations we have to deal with.”
Interviewer Patrick McGuinness then said, “Some of their lobbyists end up as candidates in Welsh Labour. Blaenau Gwent for instance.”
Mr Flynn responded, “Indeed – I wasn’t too pleased by the fact that we had a drug pusher as a candidate.”
Mr Flynn also said, “The thing that made me angriest [about the Blaenau Gwent by-election campaign] was when one of my colleagues said that [independent candidate] Dai Davies lacked validity.
Well he’s got a hell of a lot more validity than Baroness Maggie Jones [the seat’s defeated Labour candidate in last year’s general election] has got.
She’s got no validity at all, and it seemed to turn democracy on its head to have a candidate who’s been rejected by the people in the safest constituency in Britain and send her to the House of Lords.”
See also here.
In the Netherlands, Pfizer was the main financial contributor to the far Right Edmund Burke Stichting, who want to bring US style Bushite neoconservatism to Dutch politics.
Surprising, then, their link to Labour in Britain?
Not really. As the Blairite clique within Labour are neoconservative, not Left.
Pfizer scandal in Nigeria: here.
A US Senate investigation has said that pharmaceuticals transnational GlaxoSmithKline had known of heart attack risks tied to a diabetes medication years before the evidence became public: here.